TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Proteomics International Laboratories Ltd. ( (AU:PIQ) ).
Proteomics International Laboratories Ltd announced the issuance of 409,600 unquoted employee performance rights as part of an incentive scheme. These securities are restricted from transfer and will not be quoted on the ASX until the restriction period ends, indicating a strategic move to motivate and retain talent within the company.
The most recent analyst rating on (AU:PIQ) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Proteomics International Laboratories Ltd. stock, see the AU:PIQ Stock Forecast page.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd operates in the biotechnology industry, specializing in the development of diagnostic tests and analytical services. The company focuses on proteomics, which involves the study of proteins and their functions, and aims to provide innovative solutions for healthcare and research markets.
Average Trading Volume: 412,757
Technical Sentiment Signal: Sell
Current Market Cap: A$59.74M
For an in-depth examination of PIQ stock, go to TipRanks’ Overview page.